Get the Stockscreener App
91.04
1.51%
1.35
After Hours:
91.04
Zimmer Biomet Holdings Inc stock is traded at $91.04, with a volume of 1.79M.
It is up +1.51% in the last 24 hours and down -9.18% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$89.69
Open:
$89.43
24h Volume:
1.79M
Relative Volume:
0.82
Market Cap:
$17.36B
Revenue:
$8.41B
Net Income/Loss:
$760.80M
P/E Ratio:
23.64
EPS:
3.8513
Net Cash Flow:
$1.05B
1W Performance:
-4.53%
1M Performance:
-9.18%
6M Performance:
+3.88%
1Y Performance:
-6.12%
1-Day Range:
$89.24
$91.84
1-Week Range:
$89.02
$95.66
52-Week Range:
$79.12
$106.88
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
91.04 | 17.36B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-23-26 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-20-26 | Initiated | William Blair | Mkt Perform |
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jul-15-25 | Upgrade | Roth Capital | Neutral → Buy |
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet stock trades at USD 91.57, up 2.10 percent in New York trading - AD HOC NEWS
Zimmer Biomet Holdings (ZBH) Pushes Cost Reset Plans, Is It Still 17% Below Fair Value? - Yahoo Finance
Zimmer Biomet stock falls 1.31 percent despite higher 2026 guidance - AD HOC NEWS
Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Zimmer Biomet Holdings, Inc. $ZBH Holdings Lifted by State Street Corp - MarketBeat
A Look at Zimmer Biomet Holdings Inc (ZBH) After 3.3% Decline -- GF Value $125.18 vs Price $90.88 - gurufocus.com
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know - Yahoo Finance
Why Zimmer Biomet (ZBH) Stock Is Down Today - Quiver Quantitative
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now - Yahoo Finance UK
Zimmer Biomet stock slips as shares close at USD 94.32 - AD HOC NEWS
Nykredit A S Takes $3.22 Million Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet stock slips 1.1 percent ahead of the open - AD HOC NEWS
Zimmer Biomet stock holds near USD 94 as analysts see upside - AD HOC NEWS
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Zimmer Biomet stock heads into the open after a 1.2 percent gain - AD HOC NEWS
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zimmer Biomet Holdings, Inc. (ZBH) Investor Outlook: Strong Potential Upside with 12.81% Amid Robust Product Portfolio - DirectorsTalk Interviews
The Best Healthcare Stocks to Buy - Morningstar
ETFs Investing in Zimmer Biomet Holdings, Inc. Stocks - TradingView
Zimmer Biomet Holdings, Inc. rStock (RZBH) Price Prediction for 2026 to 2031 - Bybit
Zimmer Biomet to Showcase Complete Shoulder Solution Designed to Support Surgeon Flexibility - Ortho Spine News
2,177,724 Shares in Zimmer Biomet Holdings, Inc. $ZBH Purchased by Bank of America Corp DE - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is Zimmer Biomet Stock Underperforming the Nasdaq? - Yahoo Finance
Zimmer Biomet Mid-Year Report: Hips Move but Knees Take the Scenic Route - Orthopedics This Week
Zimmer Biomet (ZBH) Insider Sale: Grp Pres-Global Business Kevin Thornal Sells 5,691 Shares, Now Holds 0 - GuruFocus
Zimmer Biomet (NYSE: ZBH) leader now reports no direct stock holdings - Stock Titan
Zimmer Biomet Holdings Inc (ZBH) Shares Surge 3.3% -- What GF Sc - GuruFocus
How Zimmer Biomet’s New Americas and Robotics Leadership Structure At Zimmer Biomet Holdings (ZBH) Has Changed Its Investment Story - Yahoo Finance
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating A 15% Upside Potential - DirectorsTalk Interviews
Zimmer proposes to cut 580 jobs in Switzerland - Yahoo Finance
Engineers Gate Manager LP Makes New $6.16 Million Investment in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
California State Teachers Retirement System Purchases 26,490,456 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
BMO Capital initiates coverage on Zimmer Biomet with $95 target - scanx.trade
Kevin R. Thornal plans $529K Zimmer Biomet (NYSE: ZBH) stock sale - Stock Titan
Zimmer Biomet stock slips after Winterthur job-cut plan and leadership changes - ad-hoc-news.de
Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by Amundi - MarketBeat
Zimmer Biomet stock heads into the open after a 2.4% drop - ad-hoc-news.de
Zimmer Biomet stock slips as guidance and jobs cuts weigh - ad-hoc-news.de
Zimmer restructures Americas leadership team - Yahoo Finance
Zimmer Biomet SVP, Chief Legal & Corporate Affairs Officer Chad F. Phipps disposes of 3,000 common shares worth $295,050 - Bitget
Zimmer Biomet stock heads into the open after a 3.9 percent drop - ad-hoc-news.de
Zimmer Biomet Executive Chad F. Phipps Sells 3,000 Shares at $98.35 Each - Kalkine Media
Chad Phipps Sells 3,000 Shares of Zimmer Biomet (NYSE:ZBH) Stock - MarketBeat
Zimmer Biomet Holdings Insider Sold Shares Worth $295,050, According to a Recent SEC Filing - marketscreener.com
Zimmer Biomet (NYSE: ZBH) officer sells 3,000 shares for about $295K - Stock Titan
Sept. 3: Zimmer Biomet moving HQ, donating former one to area college - Fort Wayne Business Weekly
Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating - Moomoo
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):